172 related articles for article (PubMed ID: 38817865)
1. Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis.
Zou C; Shen J; Xu F; Ye Y; Wu Y; Xu S
J Cancer; 2024; 15(11):3510-3530. PubMed ID: 38817865
[TBL] [Abstract][Full Text] [Related]
2. GBP5 exacerbates rosacea-like skin inflammation by skewing macrophage polarization towards M1 phenotype through the NF-κB signalling pathway.
Zhou L; Zhao H; Zhao H; Meng X; Zhao Z; Xie H; Li J; Tang Y; Zhang Y
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):796-809. PubMed ID: 36367676
[TBL] [Abstract][Full Text] [Related]
3. The IRF1/GBP5 axis promotes osteoarthritis progression by activating chondrocyte pyroptosis.
Tang H; Gong X; Dai J; Gu J; Dong Z; Xu Y; Hu Z; Zhao C; Deng J; Dong S
J Orthop Translat; 2024 Jan; 44():47-59. PubMed ID: 38229660
[TBL] [Abstract][Full Text] [Related]
4. Guanylate binding protein 5 accelerates gastric cancer progression via the
Cao FY; Wang CH; Li X; Ma MZ; Tao GC; Yang C; Li K; He XB; Tong SL; Zhao QC; Su S; Song D; Zheng YB
Am J Cancer Res; 2023; 13(4):1310-1328. PubMed ID: 37168340
[TBL] [Abstract][Full Text] [Related]
5. Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy response.
Li X; Song D; Su S; He X; Cao F; Yang C; Li K; Huang S; Li C; Wang C; Zhang A; Pang P; Zheng Y
Front Genet; 2022; 13():984615. PubMed ID: 36246628
[No Abstract] [Full Text] [Related]
6. Inhibition of SF3B1 improves the immune microenvironment through pyroptosis and synergizes with αPDL1 in ovarian cancer.
Wang S; Liu Y; Xiao H; Chen Z; Yang X; Yin J; Li Y; Yuan C; Yan S; Chen G; Gao Q; Kong B; Sun C; Song K
Cell Death Dis; 2023 Nov; 14(11):775. PubMed ID: 38012150
[TBL] [Abstract][Full Text] [Related]
7. GBP5 Expression Predicted Prognosis of Immune Checkpoint Inhibitors in Small Cell Lung Cancer and Correlated with Tumor Immune Microenvironment.
Tong Q; Li D; Yin Y; Cheng L; Ouyang S
J Inflamm Res; 2023; 16():4153-4164. PubMed ID: 37750170
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
[TBL] [Abstract][Full Text] [Related]
9. Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer.
Wang M; Wu M; Liu X; Shao S; Huang J; Liu B; Liang T
Adv Sci (Weinh); 2022 Oct; 9(29):e2202914. PubMed ID: 35981886
[TBL] [Abstract][Full Text] [Related]
10. A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer.
Yang J; Wang C; Zhang Y; Cheng S; Xu Y; Wang Y
J Ovarian Res; 2023 Sep; 16(1):196. PubMed ID: 37730669
[TBL] [Abstract][Full Text] [Related]
11. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
[TBL] [Abstract][Full Text] [Related]
12. Pyroptosis and the tumor immune microenvironment: A new battlefield in ovarian cancer treatment.
Wang A; Wang Y; Du C; Yang H; Wang Z; Jin C; Hamblin MR
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189058. PubMed ID: 38113952
[TBL] [Abstract][Full Text] [Related]
13. GBP5 Repression Suppresses the Metastatic Potential and PD-L1 Expression in Triple-Negative Breast Cancer.
Cheng SW; Chen PC; Lin MH; Ger TR; Chiu HW; Lin YF
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33916322
[TBL] [Abstract][Full Text] [Related]
14. AG490, a Jak2 inhibitor, suppressed the progression of murine ovarian cancer.
Kobayashi A; Tanizaki Y; Kimura A; Ishida Y; Nosaka M; Toujima S; Kuninaka Y; Minami S; Ino K; Kondo T
Eur J Pharmacol; 2015 Nov; 766():63-75. PubMed ID: 26410360
[TBL] [Abstract][Full Text] [Related]
15. Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer.
Xu H; Lu M; Liu Y; Ren F; Zhu L
J Cancer; 2023; 14(16):3151-3168. PubMed ID: 37859811
[No Abstract] [Full Text] [Related]
16. Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-κB activation.
Cho U; Kim B; Kim S; Han Y; Song YS
Mol Carcinog; 2018 Feb; 57(2):235-242. PubMed ID: 29024042
[TBL] [Abstract][Full Text] [Related]
17. CXCL9 influences the tumor immune microenvironment by stimulating JAK/STAT pathway in triple-negative breast cancer.
Wu L; Sun S; Qu F; Sun M; Liu X; Sun Q; Cheng L; Zheng Y; Su G
Cancer Immunol Immunother; 2023 Jun; 72(6):1479-1492. PubMed ID: 36472587
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer.
Wu J; Zhu Y; Luo M; Li L
Front Immunol; 2021; 12():748221. PubMed ID: 34659246
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of liver cancer cell-secreted exosomal PSMA5 controls macrophage polarization to restrain cancer progression by blocking JAK2/STAT3 signaling.
Xie S; Li X; Yan J; Yu H; Chen S; Chen K
Immun Inflamm Dis; 2024 Feb; 12(2):e1146. PubMed ID: 38415977
[TBL] [Abstract][Full Text] [Related]
20. CTHRC1 in Ovarian Cancer Promotes M2-Like Polarization of Tumor-Associated Macrophages via Regulation of the STAT6 Signaling Pathway.
Bai Y; Yin K; Su T; Ji F; Zhang S
Onco Targets Ther; 2020; 13():5743-5753. PubMed ID: 32606786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
